Literature DB >> 8033460

Prominent white matter cavitation in an infant with Alexander's disease.

E A Klein1, A P Anzil.   

Abstract

The clinical history and autopsy findings are reported on a case of infantile Alexander's disease (AD). The patient, a white baby girl, developed seizures at age 4 months accompanied by internal hydrocephalus. She died at age 11 months following a progressive, downhill course of profound psychomotor retardation, recurrent seizures and cachexia. The general autopsy was remarkable for cachexia. The formalin fixed brain and spinal cord were studied by light and electron microscopy (EM). The brain was normal in weight for age but showed diffuse pallor of white matter and marked cavitation involving the cerebral and cerebellar subcortical white matter, most profound in the frontal lobes. Microscopically the CNS showed classic features of AD with diffuse paucity of myelin and massive proliferation of astrocytes bearing Rosenthal fibers (RF). The latter appeared as granular osmiophilic deposits associated with 8-10 nm filaments within astrocytic processes and cell bodies by EM. This case of AD is remarkable for the extreme degree of cavitation. Cavitary changes affect up to one third of typical cases of AD and are invariably present in the frontal white matter. Affected patients are generally much younger and have a shorter clinical course than AD patients without brain cavitation. The dysmyelination of AD inversely parallels the temporal sequence of normal myelination and suggests a relative resistance of early myelinated structures to the presumed astrocytic defect causing AD. Adults with de novo formation of RF's in the CNS have a varied clinical and pathological appearance, rarely show brain cavitation and should probably be distinguished from classic AD in children.

Entities:  

Mesh:

Year:  1994        PMID: 8033460

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  7 in total

Review 1.  Discrepancy between neuroimaging findings and clinical phenotype in Alexander disease.

Authors:  A Dinopoulos; J R Gorospe; J C Egelhoff; K M Cecil; P Nicolaidou; P Morehart; T DeGrauw
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Alexander disease: diagnosis with MR imaging.

Authors:  M S van der Knaap; S Naidu; S N Breiter; S Blaser; H Stroink; S Springer; J C Begeer; R van Coster; P G Barth; N H Thomas; J Valk; J M Powers
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

3.  Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.

Authors:  Heather R Minkel; Tooba Z Anwer; Kara M Arps; Michael Brenner; Michelle L Olsen
Journal:  Glia       Date:  2015-07-17       Impact factor: 7.452

4.  Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.

Authors:  Michael R Heaven; Daniel Flint; Shan M Randall; Alexander A Sosunov; Landon Wilson; Stephen Barnes; James E Goldman; David C Muddiman; Michael Brenner
Journal:  J Proteome Res       Date:  2016-06-02       Impact factor: 4.466

Review 5.  Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms.

Authors:  Marjo S van der Knaap; Marianna Bugiani
Journal:  Acta Neuropathol       Date:  2017-06-21       Impact factor: 17.088

6.  GFAP variant p. Tyr366Cys demonstrated widespread brain cavitation in neonatal Alexander disease.

Authors:  Hirokazu Takeuchi; Norimichi Higurashi; Hiroshi Kawame; Tadashi Kaname; Kumiko Yanagi; Yuichiro Nonaka; Tatsuya Hirotsu; Satoshi Matsushima; Tetsuya Shimizu; Taku Gomi; Nei Fukasawa
Journal:  Radiol Case Rep       Date:  2021-12-28

7.  Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter.

Authors:  J Patrick van der Voorn; Petra J W Pouwels; Gajja S Salomons; Frederik Barkhof; Marjo S van der Knaap
Journal:  Neuroradiology       Date:  2009-05-30       Impact factor: 2.804

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.